ENTITY
Sam Chun Dang Pharm

Sam Chun Dang Pharm (000250 KS)

4
Analysis
Health CareSouth Korea
Sam Chun Dang Pharm Co., Ltd. (SCD) develops, manufactures, and markets medicines for human health care. The Company specializes in producing medical treatment drugs as well as diagnostic drugs. SCD Pharm's products include antibiotics, respiratory stimulants, pneumonia diagnosis devices, and many others.
more
Refresh
30 May 2023 03:22

Full Details & Trading Ramifications of Official Revisions to CFD Trade Rules in Korea

This post provides comprehensive information regarding the recent updates to the CFD trade regulations in Korea, including their impact on trading...

Logo
393 Views
Share
03 Apr 2024 11:40

KRX Short Interest Weekly (Mar 29th): Posco

We analyzed KRX short interest report for the past week. We estimate short interest decreased by 2.5% WoW and highlighted short interest changes in...

Logo
275 Views
Share
14 May 2023 18:39

The Core of CFD Margin Call Risk May Lie in the JPM Counter, Not SG: Potentially Infected Names

This core of CFD margin call risk may lie in the JPM counter, not SG. This post presents eight names that are targetable for short-selling.

Logo
364 Views
Share
07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.4k Views
Share
No more insights
x